Association of CYP24A1 with survival and drug resistance in clinical cancer patients: a meta-analysis

BACKGROUND: Acquired chemo-drug resistance constantly led to the failure of chemotherapy for malignant cancers, consequently causing cancer relapse. Hence, identifying the biomarker of drug resistance is vital to improve the treatment efficacy in cancer. The clinical prognostic value of CYP24A1 rema...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Rui, Li, Hua, Jia, Lingyan, Lee, Sau Har, Jiang, Rilei, Zhang, Yujia, Hu, Xudong, Ye, Tingjie, Wang, Xiaoling, Yan, Xiaofeng, Lu, Yanlin, Sun, Zhumei, Xu, Jiatuo, Xu, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756477/
https://www.ncbi.nlm.nih.gov/pubmed/36527000
http://dx.doi.org/10.1186/s12885-022-10369-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756477/
https://www.ncbi.nlm.nih.gov/pubmed/36527000
http://dx.doi.org/10.1186/s12885-022-10369-x

Ejemplares similares